Antibody Drug Target Atlas in Oncology
- Language: English
- 172 Pages
- Published: June 2007
- Region: World
- Your are here:
- Home
- Categories
- Pharmaceuticals and Healthcare
- Pharmaceuticals
- Oncology
Oncology Drug Pathway Analyzer (Premium Version)
Oncology Drug Pathway Analyzer (Premium Version)
- Published: January 2013
- Region: World
- Bioseeker
New for 2013: Free online updates for a year
Get instant, interactive pathway modeling on almost 3,000 cancer drugs across close to 90 different cancer types.
Drug targets and their pathways are the critical link between drugs and their role in the treatment of cancer. This highly unique interactive tool is based on BioSeeker's linking of hundreds of drug targets in many different types of cancer to a wide array of pathways. The included drugs are all from early stage development to market in maturity; also featuring ceased and suspended drugs.
The Oncology Drug Pathway Analyzer is an interactive high level data tool to analyze several thousand drug-pathway connections in close to 90 different cancer indications on the fly. The tool lets you examine both single pathways and crosstalk between pathways of drugs and filter the included drugs per pathway by twelve drug specific parameters (i.e. Indication, Stage, Company, Molecular function etc.).
The Oncology Drug Pathway Analyzer is a great facilitator to realize your position and options in drug development when utilizing pathways and it significantly cuts the amount of time it takes to do so.
Read
READ MORE >
| Format | Properties | |
|---|---|---|
| Electronic (Online Access) | The report will be emailed to you. Online access is provided for this product. | This is a single user license, allowing one specific user access to the product. |
| Site License | The report will be emailed to you. Online access is provided for this product. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Enterprisewide | The report will be emailed to you. Online access is provided for this product. | This is an enterprise license, allowing all employees within your organisation access to the product. |
Note: Product cover images may vary from those shown
RELATED PRODUCTS
-
FROM
-
Analytical Tool - Cancer Immunotherapy
- Language: English
- Published: March 2013
- Region: World
FROM -
Cancer Vaccines: From First-in-Class to Best-in-Class?
- Language: English
- 1007 Pages
- Published: March 2013
- Region: World
FROM -
Pipeline: Renal Cell Cancer
- Language: English
- 83 Pages
- Published: January 2013
- Region: World
FROM -
Pain Therapeutics - Drugs, Markets and Companies
- Language: English
- 545 Pages
- Published: June 2013
- Region: World
FROM -
Personalized Medicine - Scientific and Commercial Aspects
- Language: English
- 855 Pages
- Published: June 2013
- Region: World
FROM -
Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success
- Language: English
- 367 Pages
- Published: November 2006
- Region: World
FROM -
Renal Cell Carcinoma (Event Driven)
- Language: English
- 164 Pages
- Published: November 2012
- Region: World
-
Gastric Cancer (Event Driven)
- Language: English
- 225 Pages
- Published: November 2011
- Region: World
-
Competitor Analysis - PI3K-AKT-mTOR Inhibitors
- Language: English
- 100 Pages
- Published: June 2011
- Region: World
FROM
